Literature DB >> 33755918

Lower extremity amputations in Ireland: a registry-based study.

Anna Mealy1, Sean Tierney2, Jan Sorensen3.   

Abstract

OBJECTIVE: To analyse the current provision of lower extremity amputations (LEA) in Irish public hospitals by patient characteristics and assess the potential savings for reducing numbers if a national multi-disciplinary foot protection clinic (MDFPC) was established nation-wide. DESIGN AND DATA SOURCES: Patient characteristics of LEA conducted during 2016-2019 were analysed based on discharge data from the national hospital inpatient enquiry system. Reported consequences from existing literature were used to extrapolate national consequences.
RESULTS: Public hospitals registered 3104 hospital admissions with LEA during 2016-2019. 68% (n = 2099) of these were minor amputations. About 76% (n = 1592) of minor amputations and 52% (n = 525) of major amputations were performed on patients with a diagnosis of diabetes. If the implementation of a national MDFPC programmed could reduce the number of diabetic amputations by 20%, 80 minor and 26 major amputations could be avoided annually. This would avoid nearly 3000 hospital bed days and correspond to a potential annual saving of €3 M.
CONCLUSION: LEA has severe impact on patients' lives and hospital resources. Potential savings from effective prevention strategies may offer both health improvements and cost-savings.
© 2021. Crown.

Entities:  

Keywords:  Ireland; Lower extremity amputations; Registry-based study

Mesh:

Year:  2021        PMID: 33755918     DOI: 10.1007/s11845-021-02536-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  11 in total

Review 1.  Diabetic foot infections: stepwise medical and surgical management.

Authors:  David G Armstrong; Benjamin A Lipsky
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

2.  DOCSS: doctors on-call smartphone study.

Authors:  M K O'Reilly; G J Nason; S Liddy; C W Fitzgerald; M E Kelly; C Shields
Journal:  Ir J Med Sci       Date:  2013-12-15       Impact factor: 1.568

3.  Electrophysiological dysfunction in the peripheral nervous system following spinal cord injury.

Authors:  Danny A Riley; Anthony S Burns; Monica Carrion-Jones; Timothy R Dillingham
Journal:  PM R       Date:  2011-05       Impact factor: 2.298

4.  A national approach to diabetes foot risk stratification and foot care.

Authors:  G P Leese; D Stang; D W Pearson
Journal:  Scott Med J       Date:  2011-08       Impact factor: 0.729

5.  The therapeutic efficacy of critical care units from two perspectives: a traditional cohort approach vs a new case-control methodology.

Authors:  M E Charlson; F L Sax
Journal:  J Chronic Dis       Date:  1987

6.  The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults.

Authors:  Leonor Guariguata; David Whiting; Clara Weil; Nigel Unwin
Journal:  Diabetes Res Clin Pract       Date:  2011-11-17       Impact factor: 5.602

7.  Clinical characteristics and outcomes of patients with multiple simultaneous superficial vein thrombi.

Authors:  Rishi Chopra; Luis R Leon; Nicos Labropoulos
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2018-04-18

8.  A prospective study of risk factors for foot ulceration: the West of Ireland Diabetes Foot Study.

Authors:  L Hurley; L Kelly; A P Garrow; L G Glynn; C McIntosh; A Alvarez-Iglesias; G Avalos; S F Dinneen
Journal:  QJM       Date:  2013-09-25

9.  The cost of diabetic foot ulcers and amputations to the National Health Service in England.

Authors:  M Kerr; E Barron; P Chadwick; T Evans; W M Kong; G Rayman; M Sutton-Smith; G Todd; B Young; W J Jeffcoate
Journal:  Diabet Med       Date:  2019-06-05       Impact factor: 4.359

10.  Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study.

Authors:  Nicholas Tentolouris; Sameer Al-Sabbagh; Michael G Walker; Andrew J M Boulton; Edward B Jude
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.